Two Sigma Securities’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,646
Closed -$181K 2760
2019
Q3
$181K Sell
15,646
-6,597
-30% -$69.4K ﹤0.01% 1867
2019
Q2
$222K Buy
+22,243
New +$240K ﹤0.01% 1667
2018
Q1
Sell
-14,076
Closed -$187K 3074
2017
Q4
$187K Buy
+14,076
New +$212K 0.01% 1337

Other funds holding AMAG

Two Sigma Securities's AMAG Position: Q4 2019 in Review

Two Sigma Securities sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 15,646 shares — an estimated $181K sold.

Two Sigma Securities first reported a position in AMAG in Q4 2017 and held it in 3 quarters. The position peaked at $222K in Q2 2019. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • Two Sigma Securities reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Securities sold 15,646 AMAG Pharmaceuticals shares in Q4 2019, an estimated $181K.
  • Two Sigma Securities first reported a position in AMAG Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Two Sigma Securities's AMAG Pharmaceuticals position peaked at $222K in Q2 2019.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Two Sigma Securities's 13F filing for Q4 2019, filed 14 Feb 2020.